(1)
Karthickeyan, K.; Saara, A.; Gopal, K.; Karthick, S.; Ashi, A. A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. JESM 2023, 2, 73-79.